Nuheara: Receives ethics approval to begin clinical trials

Nuheara Receives ethics approval to begin clinical trials

  • Nuheara (NUH) has received ethics approval from the Australian Hearing Human Research Ethics Committee (AHHREC) to commence its medical device clinical trial
  • The company has been working to develop multi-functional, personalised, intelligent hearing devices that augment a person’s hearing
  • The company said this supports its planned expansion into clinically tested and regulatory approved medical devices
  • The company Co-founder, Managing Director and CEO Justin Miller said National Acoustics Laboratories has now commenced recruiting for company’s medical device clinical trial
  • Recruitment has already begun for the trial, which the company says supports its planned expansion into clinically tested and regulatory approved medical devices
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Italy Fines Revolut €1.15M for Regulatory Violations

Revolut faces penalties due to non-compliance with Italian financial regulations.Highlights: Italy fines Revolut €1.15 million for regulatory breaches.The...

DeFi Platform Drift Suspends Withdrawals After Crypto Hack

Drift takes precautionary measures following security breach affecting user funds.Highlights: Drift has suspended all deposits and withdrawals after...

Cross River Bank Raises $50 Million to Accelerate Growth

The funding will enhance Cross River Bank's financial technology services.Highlights: Cross River Bank has raised $50 million in...

Kulipa Secures $62M to Enhance Stablecoin Card Issuing Infrastructure

Funding aims to strengthen cryptocurrency card services in the growing fintech market.Highlights: Kulipa raises $62M to enhance its...